HOME >> MEDICINE >> NEWS
American Society of Travel Agents urges healthy travel for consumers

rge number of those surveyed by ASTA are unsure or misinformed about how some common travel diseases, including malaria (47 percent) and vaccine-preventable hepatitis [(hepatitis A (67 percent) and hepatitis B (92 percent)] are transmitted.

"The good news is that malaria and vaccine-preventable hepatitis can be prevented with medication or vaccination," said Dr. Karl Neumann, travel health expert and director of Travel Medicine Clinic in Forest Hills, New York. "Because many travelers don't realize that they may be at risk for certain diseases while traveling, it's important that they see their healthcare professional before they embark on their trips to learn more about how to protect themselves."

The World Health Organization named malaria one of the most serious threats to international travelers, yet only 8.4 percent of those surveyed who had traveled to malaria-endemic countries took anti-malarial medications to protect themselves. In addition, a large number of U.S. travelers who had visited countries with a risk of vaccine-preventable hepatitis (VPH), hepatitis A and hepatitis B, were not immunized against these diseases, which can seriously damage the liver and may potentially be disabling or fatal (hepatitis C is not a vaccine-preventable disease). In fact, 66 percent of respondents who had visited countries with hepatitis A risk were never vaccinated against the disease. Nearly as many (58 percent) travelers who had visited countries with hepatitis B risk had never received a hepatitis B vaccine.

"These survey results highlight the importance of consulting a physician about the right protection against malaria and vaccine preventable hepatitis before traveling overseas," said Dr. Neumann. "To prevent malaria, the physician may recommend an antimalarial medication, such as Malarone, which is an option for the last minute traveler, since the regimen needs to be started only two days before departure. The physician may also recom
'"/>

Contact: Paul Kenjarski
paul_kenjarski@nyc.cohnwolfe.com
212-798-9848
Cohn & Wolfe
18-Apr-2005


Page: 1 2 3 4 5

Related medicine news :

1. Test project of patient-centered medical home model endorsed by American College of Physicians
2. Drug-eluting stent controversy explored in the American Heart Hospital Journal
3. Highlights from the August 2007 Journal of the American Dietetic Association
4. American Cancer Society to hold third annual Virtual Relay For Life in Second Life
5. High-Need Physician Workforce Incentives Act endorsed by American College of Physicians
6. African-American men understimate risk of prostate cancer
7. Highlights from the June 2007 Journal of the American Dietetic Association
8. Susan G. Komen for the Cure and American Society of Clinical Oncology partner in national initiative
9. Limiting eligibility for medical studies can omit women and African-Americans
10. African-Americans perceive people with extreme health problems as less productive and valuable
11. News from American Psychiatric Association 2007 Annual Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: American Society Travel Agents urges healthy travel for consumers

(Date:4/17/2014)... PLOS Pathogens , children who live in regions of ... immune response to infection with malaria parasites that may ... and illness and partially control the growth of malaria ... develop future interventions that prevent or mitigate the disease ... 200 million cases of malaria occur worldwide, resulting in ...
(Date:4/17/2014)... Two recent papers by a University of Colorado ... scientists develop treatments or vaccines for Dengue fever, ... other disease-causing flaviviruses. , Jeffrey S. Kieft, PhD, ... the School of Medicine and an early career ... colleagues recently published articles in the scholarly journals ...
(Date:4/17/2014)... biology team has created a new technology for ... could travel the body and selectively target cancer ... biological devices that monitor and modify human physiology ... However, no existing technology enabled bioengineers to build ... and respond in a customized fashion. , "The ...
(Date:4/17/2014)... estimated that as many as 10 million older Americans ... loneliness and isolation. , However, new research a ... older Americans for six years found that Internet ... depression by more than 30 percent. , "That,s a ... University professor of telecommunication, information studies and media who ...
(Date:4/17/2014)... 17, 2014 By discovering a new mechanism that ... stroke, researchers at UC Irvine and the Salk Institute ... limit or prevent stroke-induced brain damage. , A complex ... of death and primary reason for disability in the ... stroke and lets blood-borne material into the brain, causing ...
Breaking Medicine News(10 mins):Health News:Study sheds light on how the immune system protects children from malaria 2Health News:CU researchers discover target for treating dengue fever 2Health News:Building 'smart' cell-based therapies 2Health News:Internet use can help ward off depression among elderly 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
(Date:1/14/2014)... Mass. , Jan. 14, 2014 HeartWare ... leading innovator of less invasive, miniaturized circulatory support technologies ... today announced that it expects revenues for the fourth ... expected full-year 2013 revenues to approximately $208 million. ...
(Date:1/14/2014)... N.J. , Jan. 14, 2014 InformEx, ... and sellers of high-value chemistry, will hold the 30 th ... Miami Beach Convention Center from January 21-24. ... 3,500 attendees from top pharmaceutical, fine chemical and specialty chemical ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: